These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33367650)

  • 1. Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020.
    Tenforde MW; Kondor RJG; Chung JR; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Rao A; Kim SS; Stark TJ; Barnes JR; Wentworth DE; Patel MM; Flannery B
    Clin Infect Dis; 2021 Dec; 73(11):e4244-e4250. PubMed ID: 33367650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children.
    Olson SM; Newhams MM; Halasa NB; Feldstein LR; Novak T; Weiss SL; Coates BM; Schuster JE; Schwarz AJ; Maddux AB; Hall MW; Nofziger RA; Flori HR; Gertz SJ; Kong M; Sanders RC; Irby K; Hume JR; Cullimore ML; Shein SL; Thomas NJ; Stewart LS; Barnes JR; Patel MM; Randolph AG;
    Clin Infect Dis; 2022 Aug; 75(2):230-238. PubMed ID: 35024795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season.
    Flannery B; Kondor RJG; Chung JR; Gaglani M; Reis M; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Kim SS; Blanton L; Kniss K; Budd AP; Brammer L; Stark TJ; Barnes JR; Wentworth DE; Fry AM; Patel M
    J Infect Dis; 2020 Jan; 221(1):8-15. PubMed ID: 31665373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Vaccination on Preventing Influenza-Associated Hospitalizations Among Children During a Severe Season Associated With B/Victoria Viruses, 2019-2020.
    Campbell AP; Ogokeh C; Weinberg GA; Boom JA; Englund JA; Williams JV; Halasa NB; Selvarangan R; Staat MA; Klein EJ; McNeal M; Michaels MG; Sahni LC; Stewart LS; Szilagyi PG; Harrison CJ; Lively JY; Rha B; Patel M;
    Clin Infect Dis; 2021 Aug; 73(4):e947-e954. PubMed ID: 33502489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
    Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.
    Skowronski DM; Janjua NZ; De Serres G; Sabaiduc S; Eshaghi A; Dickinson JA; Fonseca K; Winter AL; Gubbay JB; Krajden M; Petric M; Charest H; Bastien N; Kwindt TL; Mahmud SM; Van Caeseele P; Li Y
    PLoS One; 2014; 9(3):e92153. PubMed ID: 24667168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019-2020.
    Tenforde MW; Talbot HK; Trabue CH; Gaglani M; McNeal TM; Monto AS; Martin ET; Zimmerman RK; Silveira FP; Middleton DB; Olson SM; Garten Kondor RJ; Barnes JR; Ferdinands JM; Patel MM;
    J Infect Dis; 2021 Sep; 224(5):813-820. PubMed ID: 33378531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular epidemiology of influenza viruses from Romanian patients hospitalized during the 2019/20 season.
    Miron VD; Bănică L; Săndulescu O; Paraschiv S; Surleac M; Florea D; Vlaicu O; Milu P; Streinu-Cercel A; Bilașco A; Oțelea D; Pițigoi D; Streinu-Cercel A; Drăgănescu AC
    PLoS One; 2021; 16(11):e0258798. PubMed ID: 34767579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study.
    Kissling E; Pozo F; Martínez-Baz I; Buda S; Vilcu AM; Domegan L; Mazagatos C; Dijkstra F; Latorre-Margalef N; Kurečić Filipović S; Machado A; Lazar M; Casado I; Dürrwald R; van der Werf S; O'Donnell J; Linares Dopido JA; Meijer A; Riess M; Višekruna Vučina V; Rodrigues AP; Mihai ME; Castilla J; Goerlitz L; Falchi A; Connell J; Castrillejo D; Hooiveld M; Carnahan A; Ilić M; Guiomar R; Ivanciuc A; Maurel M; Omokanye A; Valenciano M;
    Influenza Other Respir Viruses; 2023 Jan; 17(1):e13069. PubMed ID: 36702797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019.
    Melidou A; Hungnes O; Pereyaslov D; Adlhoch C; Segaloff H; Robesyn E; Penttinen P; Olsen SJ;
    Vaccine; 2020 Jul; 38(35):5707-5717. PubMed ID: 32624252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza Vaccine Effectiveness in the United States During the 2016-2017 Season.
    Flannery B; Chung JR; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Murthy K; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Rolfes MA; Spencer S; Fry AM;
    Clin Infect Dis; 2019 May; 68(11):1798-1806. PubMed ID: 30204854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.
    McLean HQ; Caspard H; Griffin MR; Poehling KA; Gaglani M; Belongia EA; Talbot HK; Peters TR; Murthy K; Ambrose CS
    Vaccine; 2017 May; 35(20):2685-2693. PubMed ID: 28408121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020.
    Dawood FS; Chung JR; Kim SS; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Dunnigan K; Foust A; Sessions W; DaSilva J; Le S; Stark T; Kondor RJ; Barnes JR; Wentworth DE; Brammer L; Fry AM; Patel MM; Flannery B
    MMWR Morb Mortal Wkly Rep; 2020 Feb; 69(7):177-182. PubMed ID: 32078591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.
    Kissling E; Valenciano M; Pozo F; Vilcu AM; Reuss A; Rizzo C; Larrauri A; Horváth JK; Brytting M; Domegan L; Korczyńska M; Meijer A; Machado A; Ivanciuc A; Višekruna Vučina V; van der Werf S; Schweiger B; Bella A; Gherasim A; Ferenczi A; Zakikhany K; O Donnell J; Paradowska-Stankiewicz I; Dijkstra F; Guiomar R; Lazar M; Kurečić Filipović S; Johansen K; Moren A;
    Influenza Other Respir Viruses; 2018 Jul; 12(4):423-437. PubMed ID: 29125681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine Effectiveness Against Pediatric Influenza Hospitalizations and Emergency Visits.
    Campbell AP; Ogokeh C; Lively JY; Staat MA; Selvarangan R; Halasa NB; Englund JA; Boom JA; Weinberg GA; Williams JV; McNeal M; Harrison CJ; Stewart LS; Klein EJ; Sahni LC; Szilagyi PG; Michaels MG; Hickey RW; Moffat ME; Pahud BA; Schuster JE; Weddle GM; Rha B; Fry AM; Patel M
    Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33020249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013.
    El Omeiri N; Azziz-Baumgartner E; Thompson MG; ; Clará W; Cerpa M; Palekar R; Mirza S; Ropero-Álvarez AM
    Vaccine; 2018 Jun; 36(24):3555-3566. PubMed ID: 28648543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.